tuzi
Lv71
4780 积分
2022-09-20 加入
-
Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog
4个月前
已完结
-
Ecological catalysis and phytoextraction: Symbiosis for future
5个月前
已完结
-
The effect of food on the relative bioavailability of rapidly dissolving immediate- release solid oral products containing highly soluble drugs
7个月前
已完结
-
Total tibio-tarsal section for tuberculosis
8个月前
已关闭
-
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
8个月前
已完结
-
Avacincaptad Pegol: First Approval By: Kang, Connie Drugs (2023), 83(15), 1447-1453 | Language: English, Database: CAplus and MEDLINE
1年前
已完结
-
Madrigal Pharmaceuticals Announces NDA Acceptance and Priority Review of the New Drug Application for Resmetirom for the Treatment of NASH with Liver Fibrosis. Retrieved September 13, 2023 from
1年前
已完结
-
A pro-drug of semaglutide intended for once weekly treatment
1年前
已关闭
-
Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II
2年前
已完结
-
A convenient preparation of an orthogonally protected Cα,Cα-disubstituted amino acid analog of lysine: 1-tert-butyloxycarbonyl-4-((9-fluorenylmethyloxycarbonyl)amino)-piperidine-4-carboxylic acid
2年前
已完结